Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Febuxostat Tablets

Approval Number

国药准字H20233932

Company芜湖杨燕制药有限公司

Registration Date

July 25, 2023

Drug Information

Generic Name

非布司他片

Dosage Form

片剂

Strength

40mg

Drug Type

化学药品

Registration Date

July 25, 2023

Company Information

Applicant Company

Company Name芜湖杨燕制药有限公司

Company Address

中国（安徽）自由贸易试验区芜湖片区九华北路生物药业科技园

Manufacturing Company

Company Name华益药业科技（安徽）有限公司

Company Address

合肥市包河区工业区上海路11号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

非布司他片 - NMPA 批准文号 | MedPath